BCL6 inhibition: A chronic GVHD twofer Journal Article


Authors: Vinci, P.; Hanash, A. M.
Article Title: BCL6 inhibition: A chronic GVHD twofer
Abstract: In this issue of Blood, Paz and colleagues demonstrate that the small molecule 79-6 is able to treat and even reverse lung injury attributable to experimental chronic graft-versus-host disease (cGVHD) by targeting B-cell lymphoma 6 (BCL6), a transcriptional regulator of T follicular helper (Tfh) cells and germinal center B cells.1 © 2019 by The American Society of Hematology
Journal Title: Blood
Volume: 133
Issue: 1
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-01-03
Start Page: 4
End Page: 5
Language: English
DOI: 10.1182/blood-2018-11-879692
PUBMED: 30606808
PROVIDER: scopus
PMCID: PMC6318425
DOI/URL:
Notes: Review -- Export Date: 1 February 2019 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Alan M Hanash
    81 Hanash
  2. Paola Vinci
    1 Vinci